Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Design and development of AbortionCareTXT, a text message programme for individuals undergoing medication abortion.

Created on 08 Oct 2026

Authors

Melissa Brooks, Hannah Richardson, Abdul-Fatawu Abdulai, Patricia Janssen, Sarah Munro, Justine Dol

Published in

BMJ sexual & reproductive health. Oct 07, 2026. Epub Oct 07, 2026.

Abstract

In Canada, medication abortion accounts for approximately 30% of the 100 000 annual abortions. Despite the advantages of privacy and autonomy, many individuals report feeling unprepared and uninformed about the medication abortion process. Mobile health (mHealth) tools offer a promising avenue for delivering discreet evidence-based support, yet remain underused in abortion care. This study aimed to develop and refine AbortionCareTXT, a text message-based programme providing timely evidence-based information and emotional support for individuals undergoing medication abortion in Canada.
Guided by user-centred intervention development principles, four rounds of semi-structured interviews were conducted with abortion providers and pregnancy-capable people. Participants reviewed and provided feedback on message content, tone, timing and usability, which informed revisions to the programme.
Twelve abortion providers and 13 pregnancy-capable people (46.2% with abortion experience) participated. Key modifications across all rounds included simplified language, added reassurance and enhanced privacy and symptom guidance. The final programme consists of 28 messages delivered over 6 weeks, covering information, support, frequently asked questions, emergency care and reminder content aligned with the usual clinical course.
The results suggest that a structured text-based intervention may be acceptable to both pregnancy-capable people and abortion providers and can address information, emotional and practical needs. AbortionCareTXT may enhance users' sense of being informed and enhance the patient experience. Future research will evaluate the programme's feasibility and real-world impact.

PMID:
42843986
Bibliographic data and abstract were imported from PubMed on 08 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement